Srinivasa T Reddy

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignee: University of California. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasa T Reddy. Retrieved from https://idiyas.com/inventor/srinivasa-t-reddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 10.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

10 out of 16,048

University of California

patents

Years Active: 2010-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10905736 - Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism (2021-02-02),

2. 10208103 - Use of HDL-related molecules to treat and prevent proinflammatory conditions (2019-02-19),

3. 9539300 - Modulating disease through genetic engineering of plants (2017-01-10),

4. 9488655 - Biomarkers for detection of early- and late-stage endometrial cancer (2016-11-08),

5. 9487575 - Compositions and methods for treatment of gynecologic cancers (2016-11-08),

6. 9241976 - Use of HDL-related molecules to treat and prevent proinflammatory conditions (2016-01-26),

7. 9110083 - Biomarkers for early detection of ovarian cancer (2015-08-18),

8. 8323915 - Biomarkers for early detection of ovarian cancer (2012-12-04),

9. 7723045 - Assays to predict atherosclerosis and dysfunctional high-density lipoprotein (2010-05-25),

10. 7670792 - Biomarkers for early detection of ovarian cancer (2010-03-02),

Title: Innovations of Srinivasa T Reddy

Introduction

Srinivasa T Reddy is a prominent inventor based in Cerritos, California. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic approaches. With a total of 10 patents to his name, his work has the potential to impact various health conditions.

Latest Patents

One of his latest patents is focused on "Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism." This invention provides improved synergistic activity between ezetimibe and the apoA-I peptide in vivo. The patent describes methods for creating these peptides, including incubating ezetimibe with an apoAI mimetic peptide in specific solutions. Another notable patent involves the use of HDL-related molecules to treat and prevent pro-inflammatory conditions. This invention highlights the potential of HDL-related molecules to prevent UV-induced cell death and oxidative stress, as well as inhibit tumor growth in various cancers.

Career Highlights

Srinivasa T Reddy is affiliated with the University of California, where he continues to advance his research and innovations. His work is characterized by a strong focus on developing therapeutic solutions that address critical health issues.

Collaborations

He has collaborated with notable colleagues, including Robin Farias-Eisner and Alan M Fogelman, to further enhance the impact of his research.

Conclusion

Srinivasa T Reddy's contributions to biomedical research through his patents and collaborations demonstrate his commitment to innovation in healthcare. His work holds promise for improving treatment options for various diseases and conditions.

Profile summary based on public USPTO records.